In this article (Clin Cancer Res 2014;20:1576–89), which was published in the March 15, 2014, issue of Clinical Cancer Research (1), there is incorrect wording in a figure title and a figure layout error. The title for Fig. 6 was incorrectly printed as “Figure 6. MLN4924 enhances the activity of BCR signaling inhibitor CAL-101 and alkylating agents in CLL.” It should read as follows: “Figure 6. MLN4924 enhances the activity of BCR signaling inhibitors in CLL.” The authors regret this error. In Fig. 3A, the label “CLL49” was mistakenly placed inside the image. The corrected version of Fig. 3 is below. The publisher regrets this error. The conclusions put forth in the article remain unchanged and unaffected by these errors.
References
1.
Godbersen
J
, Humphries
L
, Danilova
OV
, Kebbekus
PE
, Brown
JR
, Eastman
A
, et al The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells
. Clin Cancer Res
2014
;20
:1576
–89
.©2016 American Association for Cancer Research.
2016
American Association for Cancer Research.